Companies

3.6.22

3 questions to Molzym: “Our goal is to minimise the time needed for DNA analysis in sepsis diagnostics from 24 down to four hours”

Molecular diagnostics are dedicated to analysing genetic material. Just as DNA is highly complex in itself and must be isolated from other molecules, the methods and procedures in this field are highly complicated. Bremen-based company Molzym offers molecular diagnostics solutions for a wide range of pathogens that cause infectious diseases. At Potsdam Science Park, the…

18.5.22

RIPAC-LABOR – a successful business preparing for a new phase

One of the biggest business success stories at the Potsdam Science Park has been RIPAC-LABOR. After more than 18 years at the helm, successful founder and entrepreneur Dagmar Köhler-Repp has passed the mantle to Heiko Rüdiger, a veteran executive who has plans to give the company a stronger international presence, especially now that it’s part…

5.5.22

»The most important thing is: talk about your ideas, don’t keep quiet« – A Conversation with Johannes Zier from the International Start-up Service at the University of Potsdam

With over 25 years of experience supporting startups, 300 of them nurtured over the last 10 years alone, and ranked 3rd in Startup Radar 2021, Potsdam Transfer’s Start-up Service is one of Germany’s most successful. In this interview we hear from its head of, Johannes Zier, on how he and the team got to this…

24.2.22

3 Questions to Biotx.ai: „With our AI platform, we have achieved something in three months that previously took the industry several years to do“

Artificial intelligence is one of the big trending topics of our time. But what exactly can it do? Biotx.ai, a company based in the Potsdam Science Park, manages to recognize complex patterns in genomic data with its AI platform, enabling it to make precise predictions about the efficacy of new therapies. Their approach could radically…

17.2.22

3 questions to biocyc – „With our new antibody production process, we are one of the few companies in the world that are able to do this“

In a way, biocyc is one of the hidden champions of the Potsdam Science Park. Producing peptides for both the pharmaceutical industry and research as well as antibodies for cancer diagnostics, their success allows them to build their own production building in the Potsdam Science Park. In our interview, biocyc CEO Alexander Gorczyza talks about…

3.2.22

3 questions to Porous – „Quantitative ultrasound technology allows the early detection of osteoporosis.”

Osteoporosis effects billions of people worldwide and creates economic costs of about 60 billion US Dollars annually. Until recently, the early diagnosis of the disorder with conventional means has been nearly impossible. The MedTech startup Porous GmbH, a spin-off of Charité Berlin, is planning to change that. In our interview, CEO Bart Hendriks tells us…

3 questions to Molzym: “Our goal is to minimise the time needed for DNA analysis in sepsis diagnostics from 24 down to four hours”

RIPAC-LABOR – a successful business preparing for a new phase

»The most important thing is: talk about your ideas, don’t keep quiet« – A Conversation with Johannes Zier from the International Start-up Service at the University of Potsdam

3 Questions to Biotx.ai: „With our AI platform, we have achieved something in three months that previously took the industry several years to do“

3 questions to biocyc – „With our new antibody production process, we are one of the few companies in the world that are able to do this“

3 questions to Porous – „Quantitative ultrasound technology allows the early detection of osteoporosis.”

Möchten Sie aktuelle Informationen von uns erhalten?